• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTIBLE INFUSION SET 20G X 1.0 IN; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTIBLE INFUSION SET 20G X 1.0 IN; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number N/A
Medical Device Problem Code Crack (1135)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/01/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported by the customer "a leaking huber needle in the micu.There was lr (lactated ringers) infusing through the needle.The leak occurred at the y-site." no other information was provided.
 
Additional Manufacturer Narrative
The date of event was not provided by the complainant/reporter, the date reflected in this report is the date bd became aware of the event.The manufacturer has received the sample and is pending evaluation.Results are expected soon.
 
Additional Manufacturer Narrative
The information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The complaint of crack in the y-site hub is confirmed and the cause appeared to be supplier related.A 20ga x 3/4¿ w/y-site powerloc max safety infusion set was returned for evaluation.The sample showed signs of use with contaminants inside the tubing, the safety mechanism is engaged, and the tubing is clamped.Injection end caps are attached to each hub.A longitudinally aligned crack is visible in the y-site adjacent to the molding knit line.The crack occurred adjacent to the weld line, a feature in the material that occurs during the molding of the y-site component.The device involved in the reported event is a supplied component, and the supplier has been notified of this event.H3 other text : evaluation findings are in section h.11.
 
Event or Problem Description
It was reported by the customer "a leaking huber needle in the micu.There was lr (lactated ringers) infusing through the needle.The leak occurred at the y-site." no other information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERLOC MAX POWER-INJECTIBLE INFUSION SET 20G X 1.0 IN
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer Contact
johanna de oliveira
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key16590427
Report Number3006260740-2023-00953
Device Sequence Number4937763
Product Code FPA
UDI-Device Identifier00801741047350
UDI-Public(01)00801741047350
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K153440
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue Number0132010
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/15/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/01/2023
Supplement Date Received by Manufacturer05/23/2023
Initial Report FDA Received Date03/22/2023
Supplement Report FDA Received Date05/26/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-